Literature DB >> 21224393

The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.

Lola Fernández-Messina1, Omodele Ashiru, Sonia Agüera-González, Hugh T Reyburn, Mar Valés-Gómez.   

Abstract

The activating immune receptor NKG2D binds to several stress-induced ligands that are structurally different. MHC-class-I-related chain (MIC) A/B molecules have a transmembrane domain, whereas most UL16 binding proteins (ULBPs) are glycosylphosphatidylinositol (GPI)-linked molecules. The significance of this variability in membrane anchors is unclear. Here, we demonstrate that ULBP2, but not ULBP1 or ULBP3, can reach the cell surface without the GPI modification. Several proteins are expressed at the cell surface as both transmembrane and GPI-linked molecules, either via alternative splicing or by the expression of linked genes. However, to our knowledge, ULBP2 is the first single mammalian cDNA that can be expressed as either a transmembrane or a GPI-anchored protein. The rate of maturation and the levels of cell surface expression of the non-GPI-linked form were lower than those of the GPI-linked ULBP2. Nonetheless, non-GPI ULBP2 was recognised by NKG2D and triggered NK cell cytotoxicity. These data show that differences in membrane attachment by NKG2D ligands are more important for regulation of their surface expression than for cytotoxic recognition by NKG2D and emphasise that detailed characterisation of the cell biology of individual NKG2D ligands will be necessary to allow targeted modulation of this system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21224393      PMCID: PMC3021996          DOI: 10.1242/jcs.076042

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  34 in total

Review 1.  Immunobiology of human NKG2D and its ligands.

Authors:  S González; V Groh; T Spies
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

2.  Brief residence at the plasma membrane of the MHC class I-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding.

Authors:  Sonia Agüera-González; Philippe Boutet; Hugh T Reyburn; Mar Valés-Gómez
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

3.  Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands.

Authors:  Lola Fernández-Messina; Omodele Ashiru; Philippe Boutet; Sonia Agüera-González; Jeremy N Skepper; Hugh T Reyburn; Mar Valés-Gómez
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

Review 4.  The NKG2D receptor: sensing stressed cells.

Authors:  Carlos López-Larrea; Beatriz Suárez-Alvarez; Alejandro López-Soto; Antonio López-Vázquez; Segundo Gonzalez
Journal:  Trends Mol Med       Date:  2008-03-18       Impact factor: 11.951

5.  NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting.

Authors:  Roger W McGilvray; Robert A Eagle; Nicholas F S Watson; Ahmad Al-Attar; Graham Ball; Insiya Jafferji; John Trowsdale; Lindy G Durrant
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

6.  Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein.

Authors:  Philippe Boutet; Sonia Agüera-González; Susan Atkinson; Caroline J Pennington; Dylan R Edwards; Gillian Murphy; Hugh T Reyburn; Mar Valés-Gómez
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

7.  ULBP6/RAET1L is an additional human NKG2D ligand.

Authors:  Robert A Eagle; James A Traherne; James R Hair; Insiya Jafferji; John Trowsdale
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

8.  Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.

Authors:  Omodele Ashiru; Philippe Boutet; Lola Fernández-Messina; Sonia Agüera-González; Jeremy N Skepper; Mar Valés-Gómez; Hugh T Reyburn
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

Review 9.  NKG2D ligands in tumor immunity.

Authors:  N Nausch; A Cerwenka
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48.

Authors:  Richard Apps; Lucy Gardner; James Traherne; Victoria Male; Ashley Moffett
Journal:  Hum Reprod       Date:  2008-07-24       Impact factor: 6.918

View more
  16 in total

1.  A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Immunol Cell Biol       Date:  2016-01-06       Impact factor: 5.126

2.  Extracellular Mipp1 Activity Confers Migratory Advantage to Epithelial Cells during Collective Migration.

Authors:  Yim Ling Cheng; Deborah J Andrew
Journal:  Cell Rep       Date:  2015-11-25       Impact factor: 9.423

Review 3.  NKG2D Receptor and Its Ligands in Host Defense.

Authors:  Lewis L Lanier
Journal:  Cancer Immunol Res       Date:  2015-06       Impact factor: 11.151

4.  PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60.

Authors:  Wai-Hang Leung; Queenie P Vong; Wenwei Lin; David Bouck; Susanne Wendt; Erin Sullivan; Ying Li; Rafijul Bari; Taosheng Chen; Wing Leung
Journal:  J Immunol       Date:  2015-02-16       Impact factor: 5.422

Review 5.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

6.  Cutting edge: NKG2D-dependent cytotoxicity is controlled by ligand distribution in the target cell membrane.

Authors:  Emily Martinez; Joseph A Brzostowski; Eric O Long; Catharina C Gross
Journal:  J Immunol       Date:  2011-04-04       Impact factor: 5.422

7.  Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding.

Authors:  Sonia Agüera-González; Catharina C Gross; Lola Fernández-Messina; Omodele Ashiru; Gloria Esteso; Howard C Hang; Hugh T Reyburn; Eric O Long; Mar Valés-Gómez
Journal:  Eur J Immunol       Date:  2011-11-03       Impact factor: 5.532

8.  Human NKG2D-ligands: cell biology strategies to ensure immune recognition.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2012-09-25       Impact factor: 7.561

9.  NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors.

Authors:  Guranda Chitadze; Marcus Lettau; Stefanie Luecke; Ting Wang; Ottmar Janssen; Daniel Fürst; Joannis Mytilineos; Daniela Wesch; Hans-Heinrich Oberg; Janka Held-Feindt; Dieter Kabelitz
Journal:  Oncoimmunology       Date:  2015-12-10       Impact factor: 8.110

10.  The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition.

Authors:  Lindsey E Carlin; Natalya V Guseva; Michael R Shey; Zuhair K Ballas; Jonathan W Heusel
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.